Allergic skin disease: major highlights and recent advances.
AD, urticaria, and ACD account for a large percentage of the skin disorders that present at medical offices and emergency departments. With a high degree of morbidity, these diseases can be extremely difficult to manage. Consequently, these diseases continue to be the focus of much of the new research in the field. Recent studies have furthered the understanding of the complex relationship between immune and nonimmune factors in the pathogenesis of these disorders. This research has quickly led to the development of new treatment modalities and protocols for patient care, especially for AD. However, further discovery will be necessary to optimize the management of these often-vexing conditions.
Nichols
Kim M
KM
Skin Specialty Group, 150 East 58th Street, 3rd Floor Annex, New York, NY 10155, USA.
Cook-Bolden
Fran E
FE
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D017449:Dermatitis, Allergic Contact / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D014581:Urticaria / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D014807:Vitamin D / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D005938:Glucocorticoids; D014807:Vitamin D